Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP443 | DOI: 10.1530/endoabs.110.EP443

ECEESPE2025 ePoster Presentations Diabetes and Insulin (245 abstracts)

Factors associated with gestational weight gain in pregnant women with gestational diabetes mellitus

Gintare Naskauskiene 1,2 , Diana Ramasauskaite 1,2 , Agne Bartuleviciene 1,2 , Gintautas Domza 1,2 & Zydrune Visockiene 1,2


1Vilnius University Faculty of Medicine, Vilnius, Lithuania; 2Vilnius University Hospital Santaros klinikos, Vilnius, Lithuania


JOINT512

Background: Studies disagree that higher pre-pregnancy body mass index (pre-BMI) is associated with more significant weight gain during pregnancy. We aimed to assess factors associated with GWG in women with gestational diabetes mellitus (GDM).

Methods: The study involved 215 singleton pregnant women diagnosed with GDM who delivered at Vilnius University Hospital Santaros Klinikos from 2019 to 2023. Based on pre-BMI, women were categorized into group 1 - BMI < 18.5- 24.9 kg/m2; group 2-BMI 25-29.9; group 3 - BMI ≥ 30. According to the Institute of Medicine, the cut-off points for weight gain were set at ≤16 kg, ≤11.5 kg, and ≤9 kg for groups 1, 2, and 3, respectively. The association of pre-BMI, fasting plasma glucose up to 14 weeks of gestation (FG14w), FG, fasting insulin (FI), HOMA-IR, lipid profile, and CRP at weeks 24-28 with GWG was analyzed.

Results: There were 123 (57.2%),52 (24.2%) and 40 (18.6%) women in group 1, 2 and 3 respectively. The mean age was 31.9 ± SD 4.05 and did not differ between the groups. Excess weight gained 22 (17.9%), 14 (26.9%), and 12 (30%) of women in groups 1, 2, and 3, respectively. The biggest GWG was in group 1 – 12.5 ±4.9 kg, followed by groups 2- 8.9±5.5 and 3 - 5.7±5.5 (P<0.001). HOMA IR was 2.0 ± 1.4, 3.0 ± 2.4, and 4.4 ± 3.4 (P<0.001); HDL chol - 2.0 ± 0.4, 1.9 ± 0.4 and 1.7 ± 0.3 (P<0.001) in group 1, 2 and 3 respectively. FG14w, FG24-28w, hCRP, triglycerides (TG), and FI differed significantly between the groups (P<0,001 for all). Pre-BMI, HDL chol, and FG24-28w explained 24% of GWG variance in the whole group (R2 adjusted = 0.24, P<0.001). Only HDL chol correlated significantly with GWG in group 2, explaining 13% of the variance (R2 adjusted = 0.13, P = 0.005) and resulting in a significant OR of 19.2 (95% CI 2.2-166.4) and AUC of 0.81 (95% CI 0.6 - 0.9). None of the variables demonstrated a statistically significant association with GWG in groups 1 and 3.

Conclusions: GDM women with the highest pre-BMI gained the least weight during pregnancy. Pre-BMI, HDL chol, and FG24-28w were significant determinants of GWG in the whole group, but only HDL chol remained significant in women with pre-pregnancy overweight. Further research is needed to explore other possible factors related to GWG in women with GDM.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches